GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world's poor. It was the second time the rankings, which were created in 2008, have been issued. This time, 95 per cent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information;...

The ministries of environment and science seem to have resolved their differences over who will govern the entry of genetically modified (GM) crops in India. The controversial genetic engineering approval committee, or GEAC, which currently gives the nod for the commercial release of GM crops, is likely to be integrated with a biotechnology regulator proposed by the science ministry, two ministry officials said on condition of anonymity. This will relegate GEAC, which...

At first glance, the vegetable patches in this north Indian village look no different from the many small, spare farms that dot the country. But up close, visitors can see some curious experiments: insect traps made with reusable plastic bags; bamboo poles helping bitter gourd grow bigger and straighter; and seedlings germinating from plastic trays under a fine net. These are low-tech innovations, to be sure. But they are crucial...

Bacillus Thuringiensis Brinjal, popularly known as Bt brinjal, is at the centre of a major controversy in India. Bt brinjal, a genetically modified strain created by India's number one seeds company Mahyco in collaboration with American multinational Monsanto, claims to improve yields and help the agriculture sector. However, the debate over the safety of Bt brinjal continues with mixed views from scientists working for the government, farmers and environment activists. Environment activists says...

The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated...